Rishiva-LS Tablet
Marketer
Intigus Pharmaceutical Private Limited
Salt Composition
Risperidone (2mg) + Trihexyphenidyl (2mg)
Overview Rishiva-LS Tablet
Rishiva-LS tablets combine medications to manage schizophrenia symptoms. Their mechanism involves regulating neurotransmitters influencing cognitive function. Rishiva-LS may be taken with or without food, ideally at bedtime, consistently each day for optimal therapeutic levels. Always follow your doctor's prescribed dosage and duration. If a dose is missed, take it immediately upon recollection. Abrupt cessation is strongly discouraged; consult your doctor before stopping treatment to avoid symptom exacerbation. Nausea, constipation, and dry mouth are frequent side effects. Initial postural hypotension may occur; rise slowly from a seated or lying position. Drowsiness and dizziness are also possible; avoid activities requiring alertness until the drug's effects are known. Weight gain, elevated blood sugar, and cholesterol are potential side effects mitigated by healthy diet and exercise. Disclose all other medications to your physician, as interactions may alter Rishiva-LS's efficacy. Notify your doctor of pregnancy, pregnancy plans, or breastfeeding.
Uses of Rishiva-LS Tablet
Split personality disorder
Major Benefits of Rishiva-LS Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Rishiva-LS Tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, though consistent timing is recommended.
Common Side effects of Rishiva-LS Tablet:
- Nausea
- Constipation
- Dryness in mouth
- Weight gain
- Sleepiness
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Increased prolactin level in blood
- Nervousness
How to use Rishiva-LS Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Rishiva-LS Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Rishiva-LS Tablets can be taken with or without food, although consistent timing is recommended.
How Rishiva-LS Tablet works:
Rishiva-LS Tablets contain Risperidone and Trihexyphenidyl, acting synergistically. Risperidone, an atypical antipsychotic, modulates dopamine and serotonin neurotransmitter levels, thereby improving cognitive function, mood, and behavior. Trihexyphenidyl, an anticholinergic agent, counteracts neurological imbalances associated with Parkinson's disease and certain adverse effects of antipsychotic medications.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Rishiva-LS tablets and alcohol can lead to significant sedation.
PregnancyCONSULT YOUR DOCTOR
Use of Rishiva-LS Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Rishiva-LS Tablets while breastfeeding is potentially hazardous. Available human data indicates a possibility of the medication transferring to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Rishiva-LS Tablet side effects. These side effects can include blurred vision, dizziness, mild nausea, and, in some instances, mental confusion, potentially impacting driving safety.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Rishiva-LS Tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Rishiva-LS Tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Rishiva-LS Tablet :
Should you forget a Rishiva-LS Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Rishiva-LS Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience (Central Nervous System) |
3,018 People bought this recently